Rare diseases
Investigational molecules
Locations
Study on Belantamab Mafodotin for Patients with Relapsed or Refractory Multiple Myeloma
FranceLong-Term Safety Study of Inhaled Imatinib for Patients with Pulmonary Arterial Hypertension
FranceStudy of Datopotamab Deruxtecan and Durvalumab for Adults with Untreated Triple-Negative or Hormone Receptor-Low/HER2-Negative Breast Cancer
FranceStudy on the Effects of Dexpramipexole for Adolescents and Adults with Severe Eosinophilic Asthma
FranceStudy on RYZ101 for Patients with Advanced Gastroenteropancreatic Neuroendocrine Tumors After Previous Treatment
FranceStudy on Berzosertib and Gemcitabine for Adults with Advanced or Metastatic Soft-Tissue Leiomyosarcomas
FranceStudy Comparing Camizestrant and Palbociclib with Anastrozole and Palbociclib for Patients with ER-Positive, HER2-Negative Advanced Breast Cancer Without Prior Treatment
FranceStudy of adagrasib in elderly patients (70 years or older) or patients with poor performance status who have KRAS G12C mutation-positive non-small cell lung cancer
FranceStudy of Nivolumab or Placebo for Patients with Removed Esophageal or Gastroesophageal Junction Cancer
FranceStudy of Olaparib and Abiraterone for Men with Advanced Prostate Cancer Resistant to Hormone Therapy
FranceStudy on the Effects of AMX0035 (Phenylbutyrate and Ursodoxicoltaurine) in Patients with Progressive Supranuclear Palsy
FranceStudy on the Safety of CRD-4730 for Patients with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
